Combination therapy of HIV fusion/ entry inhibitors targeting gp41

Details for Australian Patent Application No. 2009281992 (hide)

Owner New York Blood Center

Inventors Jiang, Shibo; Pan, Chungen

Agent Pizzeys

Pub. Number AU-A-2009281992

PCT Pub. Number WO2010/019717

Priority 61/088,571 13.08.08 US

Filing date 12 August 2009

Wipo publication date 18 February 2010

International Classifications

C07K 14/16 (2006.01) Peptides having more than 20 amino acids

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A61K 39/21 (2006.01) Medicinal preparations containing antigens or antibodies - Retroviridae, e.g. equine infectious anemia virus

Event Publications

17 February 2011 PCT application entered the National Phase

  PCT publication WO2010/019717 Priority application(s): WO2010/019717

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009281998-Antimicrobial gel formulations

2009281983-Intelligent automatic shoe and cartridge